Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cells

Bohnenkamp H, Burchell J, Taylor-Papadimitriou J, Noll T (2005)
Journal of Immunological Methods 294(1-2): 67-80.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Bohnenkamp, H; Burchell, J; Taylor-Papadimitriou, J; Noll, ThomasUniBi
Journal of Immunological Methods
Page URI


Bohnenkamp H, Burchell J, Taylor-Papadimitriou J, Noll T. Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cells. Journal of Immunological Methods. 2005;294(1-2):67-80.
Bohnenkamp, H., Burchell, J., Taylor-Papadimitriou, J., & Noll, T. (2005). Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cells. Journal of Immunological Methods, 294(1-2), 67-80. https://doi.org/10.1016/j.jim.2004.08.010
Bohnenkamp, H., Burchell, J., Taylor-Papadimitriou, J., and Noll, T. (2005). Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cells. Journal of Immunological Methods 294, 67-80.
Bohnenkamp, H., et al., 2005. Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cells. Journal of Immunological Methods, 294(1-2), p 67-80.
H. Bohnenkamp, et al., “Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cells”, Journal of Immunological Methods, vol. 294, 2005, pp. 67-80.
Bohnenkamp, H., Burchell, J., Taylor-Papadimitriou, J., Noll, T.: Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cells. Journal of Immunological Methods. 294, 67-80 (2005).
Bohnenkamp, H, Burchell, J, Taylor-Papadimitriou, J, and Noll, Thomas. “Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cells”. Journal of Immunological Methods 294.1-2 (2005): 67-80.

13 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Automated generation of immature dendritic cells in a single-use system.
Kozbial A, Bhandary L, Collier BB, Eickhoff CS, Hoft DF, Murthy SK., J Immunol Methods 457(), 2018
PMID: 29625078
Flt3 ligand induces monocyte proliferation and enhances the function of monocyte-derived dendritic cells in vitro.
Kim SW, Choi SM, Choo YS, Kim IK, Song BW, Kim HS., J Cell Physiol 230(8), 2015
PMID: 25215878
Anti-inflammatory effects of the willow bark extract STW 33-I (Proaktiv(®)) in LPS-activated human monocytes and differentiated macrophages.
Bonaterra GA, Heinrich EU, Kelber O, Weiser D, Metz J, Kinscherf R., Phytomedicine 17(14), 2010
PMID: 20570123
Using global gene expression patterns to characterize Annexin V positive and negative human monocytes in culture.
Lund PK, Øvstebø R, Møller AS, Olstad OK, Landsverk KS, Hellum M, Kierulf P., Scand J Clin Lab Invest 69(2), 2009
PMID: 18951241
Comparative effects of aspirin and NO-releasing aspirins on differentiation, maturation and function of human monocyte-derived dendritic cells in vitro.
Bufan B, Mojsilović S, Vucićević D, Vucević D, Vasilijić S, Balint B, Colić M., Int Immunopharmacol 9(7-8), 2009
PMID: 19341823
Characterizing the glycome of the mammalian immune system.
Haslam SM, Julien S, Burchell JM, Monk CR, Ceroni A, Garden OA, Dell A., Immunol Cell Biol 86(7), 2008
PMID: 18725885
Monitoring tolerance after human liver transplantation.
Wieërs G, Gras J, Bourdeaux C, Truong DQ, Latinne D, Reding R., Transpl Immunol 17(2), 2007
PMID: 17306738
Influence of heat stress on human monocyte-derived dendritic cell functions with immunotherapeutic potential for antitumor vaccines.
Hatzfeld-Charbonnier AS, Lasek A, Castera L, Gosset P, Velu T, Formstecher P, Mortier L, Marchetti P., J Leukoc Biol 81(5), 2007
PMID: 17311933
The influence of different culture microenvironments on the generation of dendritic cells from non-small-cell lung cancer patients.
Krawczyk P, Wojas K, Milanowski J, Roliński J, Roliński J., Arch Immunol Ther Exp (Warsz) 55(6), 2007
PMID: 18060367
Culture medium and protein supplementation in the generation and maturation of dendritic cells.
Royer PJ, Tanguy-Royer S, Ebstein F, Sapede C, Simon T, Barbieux I, Oger R, Gregoire M., Scand J Immunol 63(6), 2006
PMID: 16764693

43 References

Daten bereitgestellt von Europe PubMed Central.

Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides.
Alexander J, Sidney J, Southwood S, Ruppert J, Oseroff C, Maewal A, Snoke K, Serra HM, Kubo RT, Sette A., Immunity 1(9), 1994
PMID: 7895164
Primary cultures of human blood-born macrophages grown on hydrophobic teflon membranes.
Andreesen R, Picht J, Lohr GW., J. Immunol. Methods 56(3), 1983
PMID: 6833764
Large-scale generation of mature monocyte-derived dendritic cells for clinical application in cell factories.
Berger TG, Feuerstein B, Strasser E, Hirsch U, Schreiner D, Schuler G, Schuler-Thurner B., J. Immunol. Methods 268(2), 2002
PMID: 12215381
Identification of HLA-A2-restricted T-cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies.
Brossart P, Heinrich KS, Stuhler G, Behnke L, Reichardt VL, Stevanovic S, Muhm A, Rammensee HG, Kanz L, Brugger W., Blood 93(12), 1999
PMID: 10361129
Generation of antigen-loaded dendritic cells in a serum-free medium using different cytokine combinations.
Buchler T, Hajek R, Bourkova L, Kovarova L, Musilova R, Bulikova A, Doubek M, Svobodnik A, Mareschova I, Vanova P, Tuzova E, Vidlakova P, Vorlicek J, Penka M., Vaccine 21(9-10), 2003
PMID: 12547597
Annexin V expression in apoptotic peripheral blood lymphocytes: an electron microscopic evaluation.
Cornelissen M, Philippe J, De Sitter S, De Ridder L., Apoptosis 7(1), 2002
PMID: 11773704
Optimizing preparation of normal dendritic cells and bcr-abl+ mature dendritic cells derived from immunomagnetically purified CD14+ cells.
Dietz AB, Bulur PA, Erickson MR, Wettstein PJ, Litzow MR, Wyatt WA, Dewald GW, Tefferi A, Pankratz VS, Vuk-Pavlovic S., J. Hematother. Stem Cell Res. 9(1), 2000
PMID: 10738977
Monocyte enrichment from leukapharesis products for the generation of DCs by plastic adherence, or by positive or negative selection.
Felzmann T, Witt V, Wimmer D, Ressmann G, Wagner D, Paul P, Huttner K, Fritsch G., Cytotherapy 5(5), 2003
PMID: 14578101
Dendritic cell vaccines for cancer treatment.
Gabrilovich DI., Curr. Opin. Mol. Ther. 4(5), 2002
PMID: 12435046
Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2.
Gotch F, Rothbard J, Howland K, Townsend A, McMichael A., Nature 326(6116), 1987
PMID: 2437457
Monocyte-derived dendritic cells: development of a cellular processor for clinical applications.
Goxe B, Latour N, Bartholeyns J, Romet-Lemonne JL, Chokri M., Res. Immunol. 149(7-8), 1998
PMID: 9851516
Advantages of hydrophobic culture bags over flasks for the generation of monocyte-derived dendritic cells for clinical applications.
Guyre CA, Fisher JL, Waugh MG, Wallace PK, Tretter CG, Ernstoff MS, Barth RJ Jr., J. Immunol. Methods 262(1-2), 2002
PMID: 11983221
Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.
Kawakami Y, Eliyahu S, Sakaguchi K, Robbins PF, Rivoltini L, Yannelli JR, Appella E, Rosenberg SA., J. Exp. Med. 180(1), 1994
PMID: 7516411
Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics.
Kerr JF, Wyllie AH, Currie AR., Br. J. Cancer 26(4), 1972
PMID: 4561027
Flow cytometric evaluation of apoptosis, necrosis and recovery when culturing monocytes.
Lund PK, Westvik AB, Joo GB, Ovstebo R, Haug KB, Kierulf P., J. Immunol. Methods 252(1-2), 2001
PMID: 11334964
The fate of monocytes during 24 h of culture as revealed by flow cytometry and electron microscopy.
Lund PK, Namork E, Brorson SH, Westvik AB, Joo GB, Ovstebo R, Kierulf P., J. Immunol. Methods 270(1), 2002
PMID: 12379339
Optimized culture conditions for the generation of dendritic cells from peripheral blood monocytes.
Moldenhauer A, Nociari MM, Dias S, Lalezari P, Moore MA., Vox Sang. 84(3), 2003
PMID: 12670372
Generation of dendritic cells from CD14+ monocytes positively selected by immunomagnetic adsorption for multiple myeloma patients enrolled in a clinical trial of anti-idiotype vaccination.
Motta MR, Castellani S, Rizzi S, Curti A, Gubinelli F, Fogli M, Ferri E, Cellini C, Baccarani M, Lemoli RM., Br. J. Haematol. 121(2), 2003
PMID: 12694245
Flow cytometric analysis of T cell proliferation in a mixed lymphocyte reaction with dendritic cells.
Nguyen XD, Eichler H, Dugrillon A, Piechaczek C, Braun M, Kluter H., J. Immunol. Methods 275(1-2), 2003
PMID: 12667670
Mature myeloid dendritic cells for clinical use prepared from CD14+ cells isolated by immunomagnetic adsorption.
Padley DJ, Dietz AB, Gastineau DA, Vuk-Pavlovic S., J. Hematother. Stem Cell Res. 10(3), 2001
PMID: 11454318
Molecular and functional characteristics of dendritic cells generated from highly purified CD14+ peripheral blood monocytes.
Pickl WF, Majdic O, Kohl P, Stockl J, Riedl E, Scheinecker C, Bello-Fernandez C, Knapp W., J. Immunol. 157(9), 1996
PMID: 8892615
Generation of functional dendritic cells for potential use in the treatment of acute lymphoblastic leukemia.
Pospisilova D, Borovickova J, Polouckova A, Spisek R, Sediva A, Hrusak O, Stary J, Bartunkova J., Cancer Immunol. Immunother. 51(2), 2002
PMID: 11904731
Large-scale monocyte enrichment coupled with a closed culture system for the generation of human dendritic cells.
Pullarkat V, Lau R, Lee SM, Bender JG, Weber JS., J. Immunol. Methods 267(2), 2002
PMID: 12165439
Efficient presentation of tumor idiotype to autologous T cells by CD83(+) dendritic cells derived from highly purified circulating CD14(+) monocytes in multiple myeloma patients.
Ratta M, Curti A, Fogli M, Pantucci M, Viscomi G, Tazzari P, Fagnoni F, Vescovini R, Sansoni P, Tura S, Lemoli RM., Exp. Hematol. 28(8), 2000
PMID: 10989194
Visualization of cell death in vivo with the annexin A5 imaging protocol.
Reutelingsperger CP, Dumont E, Thimister PW, van Genderen H, Kenis H, van de Eijnde S, Heidendal G, Hofstra L., J. Immunol. Methods 265(1-2), 2002
PMID: 12072183
Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanoma.
Romero P, Gervois N, Schneider J, Escobar P, Valmori D, Pannetier C, Steinle A, Wolfel T, Lienard D, Brichard V, van Pel A, Jotereau F, Cerottini JC., J. Immunol. 159(5), 1997
PMID: 9278327
The use of dendritic cells in cancer immunotherapy.
Schuler G, Schuler-Thurner B, Steinman RM., Curr. Opin. Immunol. 15(2), 2003
PMID: 12633662
Clinical-scale generation of dendritic cells in a closed system.
Sorg RV, Ozcan Z, Brefort T, Fischer J, Ackermann R, Muller M, Wernet P., J. Immunother. 26(4), 2003
PMID: 12843800
Effects of leukapheresis protocol, cell processing and cryopreservation on the generation of monocyte-derived DC for immune therapy.
Tazbirkova A, Okai M, Horley DC, Crough TM, Maksoud A, Nieda M, Nicol AJ., Cytotherapy 5(1), 2003
PMID: 12745589
Generation of large numbers of dendritic cells in a closed system using Cell Factories.
Tuyaerts S, Noppe SM, Corthals J, Breckpot K, Heirman C, De Greef C, Van Riet I, Thielemans K., J. Immunol. Methods 264(1-2), 2002
PMID: 12191517
Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.
Valmori D, Fonteneau JF, Lizana CM, Gervois N, Lienard D, Rimoldi D, Jongeneel V, Jotereau F, Cerottini JC, Romero P., J. Immunol. 160(4), 1998
PMID: 9469433
Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure.
van Engeland M, Nieland LJ, Ramaekers FC, Schutte B, Reutelingsperger CP., Cytometry 31(1), 1998
PMID: 9450519
Flow cytometry of apoptotic cell death.
Vermes I, Haanen C, Reutelingsperger C., J. Immunol. Methods 243(1-2), 2000
PMID: 10986414


Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®


PMID: 15604017
PubMed | Europe PMC

Suchen in

Google Scholar